NCT03480009View on ClinicalTrials.gov

Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion

PHASE3CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

July 28, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Abortion in First Trimester
Interventions
DRUG

Dextromethorphan Hydrobromide

Dextromethorphan capsule

DRUG

Avicel PH101 (Microcrystalline Cellulose NF) for Compounding

Placebo capsule

DRUG

Oxycodone

Participants may opt for the narcotic receiving arms of the study, before being randomized to dextromethorphan/placebo.

Trial Locations (2)

15213

Center for Family Planning Research, Magee-Womens Hospital, Pittsburgh

Planned Parenthood of Western Pennsylvania, Pittsburgh

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

Study Investigator-Sponsor

OTHER

NCT03480009 - Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion | Biotech Hunter | Biotech Hunter